Stanford Movement Disorders Center News

Interview with Helen Bronte-Stewart, principal investigator, QDG

Helen Bronte-Stewart discusses Quantitative Digitography (QDG), a unique, remote technology that provides health care providers with quantitative, validated measures of all motor symptoms of Parkinson’s disease. Data from alternating finger tapping on the digitography device is analyzed in our HIPAA-compliant cloud-based service, and metrics are available to the provider in the electronic medical record in real time.

The future of movement disorders

Helen Bronte-Stewart is a neurologist and an expert in movement disorders, like Parkinson’s. She says new approaches, such as closed-loop deep-brain stimulation, and new digital health technologies that chart subtle changes in movement are reshaping the field, leading to new understandings and new treatments for this once-untreatable disease. To modulate behavior, you first have to measure it, Bronte-Stewart tells host Russ Altman. It’s the future of movement disorders in this episode of Stanford Engineering’s The Future of Everything podcast.

Parkinson's Disease Biomarker Found

In an enormous leap forward in the understanding of Parkinson’s disease (PD), researchers have discovered a new tool that can reveal a key pathology of the disease: abnormal alpha-synuclein — known as the “Parkinson’s protein” — in brain and body cells. The breakthrough, announced last night as it was published in the scientific journal The Lancet Neurology, opens a new chapter for research, with the promise of a future where every person living with Parkinson’s can expect improved care and treatments — and newly diagnosed individuals may never advance to full-blown symptoms.

Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson’s disease progression

A study led by Andreas Keller, visiting faculty at Stanford, along with Kathleen Poston and Tony Wyss-Coray, reports the longitudinal profiling of circulating small noncoding RNAs in the blood of patients with Parkinson's and identifies several microRNAs as potential diagnostic and prognostic biomarkers.

Safety of Plasma Infusions in Parkinson's Disease

The International Parkinson and Movement Disorder Society (MDS) has ranked our article as the top Movement Disorders article of July 2020.

How hacking the human heart could replace pill popping

A new generation of “smart” implantable devices could replace traditional medication to treat a range of chronic conditions, including cardiac disease. Twitter: @geditorial_uk

Addressing Neuropsychiatric Symptoms in Huntington Disease: Expert Interview

Veronica Santini, MD discusses neuropsychiatric symptoms associated with Huntington Disease with Neurology Advisor.

Stanford announces new Lewy Body Dementia (LBD) Research Center of Excellence

In December 2017 researchers from across the country joined in the first-ever comprehensive network of research centers to conduct LBD clinical trials, provide community outreach, and expand professional continuing medical education. Representing 24 of medicine’s most prestigious academic medical research centers, these Research Centers of Excellence will help to streamline and standardize LBD science while connecting patients and families with the latest opportunities to participate in LBD clinical trials.

Parkinson's patients take to the dance floor

Finding the rhythm is half the fun of dancing, but it takes a little more effort when your body is wracked by Parkinson's Disease. But in a brand new dance studio at Stanford's Neuroscience Health Center, patients are able to hit the floor with the help of professional dancer Damara Vita Ganley and a program designed to help them get in touch with their bodies.